Neurology in the Media
New Drugs That Block a Brain Chemical Are Game Changers for Some Migraine Sufferers
Richard Lipton, M.D., discusses the use of a newer class of migraine drugs known as gepants, which target a neurotransmitter implicated in migraine. Dr. Lipton is Edwin S. Lowe Professor and vice chair of the Saul R. Korey Department of Neurology at Einstein, and director of the Montefiore Headache Center.
(Sunday, Mar 28, 2021)
The Science of Migraines
Dawn Buse, Ph.D., describes the triggers and phases of migraines and explains that a variety of treatments are available to people who suffer from the debilitating headaches. Dr. Buse is clinical professor in the Saul R. Korey Department of Neurology.
(Saturday, Mar 27, 2021)
coverage on other stories
Related Einstein News
read more